Differences_NNS between_IN United_NNP Kingdom_NNP and_CC United_NNP States_NNPS generally_RB accepted_VBN accounting_NN principles_NNS for_IN the_DT year_NN ended_VBD 31_CD December_NNP 2002_CD Profit_NN and_CC loss_NN account_NN Adjustments_NNP to_TO the_DT loss_NN for_IN the_DT period_NN under_IN UK_NNP GAAP_NNP and_CC the_DT net_JJ loss_NN under_IN US_NNP GAAP_NNP are_VBP as_IN follows_VBZ :_: Year_NN ended_VBD Year_NN ended_VBD Notes_NNP 31_CD Dec_NNP 2002_CD 31_CD Dec_NNP 2001_CD Loss_NN for_IN the_DT period_NN under_IN UK_NNP GAAP_NNP 45.8_CD 55.5_CD US_NNP GAAP_NNP adjustments_NNS :_: Revenue_NN recognition_NN i_FW 12.7_CD 13.1_CD Medeva_NNP goodwill_NN adjustments_NNS ii_VBP 3.6_CD 1.4_CD Amortisation_NNP of_IN goodwill_NN and_CC other_JJ intangibles_NNS iii_FW 39.8_CD 14.6_CD Inventory_NNP adjustment_NN iv_NN 0.8_CD Pension_NN costs_VBZ 1.9_CD 0.8_CD Stock_NNP based_VBN compensation_NN v_NN 7.2_CD 2.1_CD Unrealised_JJ gains_NNS on_IN derivative_JJ financial_JJ instruments_NNS vi_FW 6.9_CD 0.4_CD Deferred_VBN taxation_NN vii_NN 5.1_CD 5.2_CD Net_JJ loss_NN before_IN cumulative_JJ effect_NN of_IN change_NN in_IN accounting_NN policy_NN 15.2_CD 87.3_CD Cumulative_JJ effect_NN of_IN change_NN in_IN accounting_NN policy_NN due_JJ to_TO adoption_NN of_IN SFAS_NNP 133_CD vi_FW 1.5_CD Net_JJ loss_NN as_IN adjusted_VBN to_TO accord_VB with_IN US_NNP GAAP_NNP 15.2_CD 85.8_CD Shareholders_NNS funds_NNS Adjustments_NNS between_IN shareholders_NNS funds_NNS under_IN UK_NNP GAAP_NNP and_CC US_NNP GAAP_NNP are_VBP as_IN follows_VBZ :_: Year_NN ended_VBD Year_NN ended_VBD Notes_NNP 31_CD Dec_NNP 2002_CD 31_CD Dec_NNP 2001_CD Shareholders_NNS funds_NNS under_IN UK_NNP GAAP_NNP 564.4_CD 619.2_CD US_NNP GAAP_NNP adjustments_NNS :_: Revenue_NN recognition_NN i_FW 25.8_CD 13.1_CD Goodwill_NNP and_CC intangibles_NNS iii_FW 163.2_CD 148.3_CD Pensions_NNP 0.2_CD 2.1_CD Pensions_NNS other_JJ comprehensive_JJ income_NN ix_NN 14.0_CD Unrealised_JJ gains_NNS on_IN derivative_JJ financial_JJ instruments_NNS vi_VBP 8.8_CD 1.9_CD Employee_NNP Share_NNP Ownership_NNP Plan_NNP viii_NN 0.3_CD 0.3_CD Deferred_VBN taxation_NN vii_NN 5.1_CD Shareholders_NNS funds_NNS as_IN adjusted_VBN to_TO accord_VB with_IN US_NNP GAAP_NNP 696.5_CD 763.2_CD Restated_VBN in_IN accordance_NN with_IN Form_NN 20F_CD filed_VBN with_IN the_DT US_NNP SEC_NNP for_IN the_DT year_NN ended_VBD 31_CD December_NNP 2001_CD ._.
78_CD Celltech_NNP Annual_JJ Report_NNP 2002_CD Notes_NNS :_: i_FW Revenue_NN recognition_NN Under_IN UK_NNP GAAP_NNP ,_, non-refundable_JJ licence_NN fee_NN revenue_NN is_VBZ recognized_VBN when_WRB earned_VBN ._.
Refundable_JJ licence_NN fees_NNS are_VBP deferred_VBN until_IN such_JJ time_NN as_IN they_PRP are_VBP no_RB longer_RB refundable_JJ ,_, otherwise_RB the_DT individual_JJ elements_NNS such_JJ as_IN milestones_NNS and_CC R&D_NNP funding_NN are_VBP accounted_VBN for_IN separately_RB based_VBN on_IN the_DT revenue_NN recognition_NN criteria_NNS set_VBN out_RP in_IN note_NN 1_CD to_TO the_DT accounts_NNS ._.
US_NNP GAAP_NNP requires_VBZ in_IN most_JJS circumstances_NNS the_DT deferral_NN of_IN non-refundable_JJ upfront_JJ licence_NN fees_NNS and_CC other_JJ income_NN received_VBN under_IN a_DT contract_NN where_WRB there_EX is_VBZ a_DT continuing_VBG involvement_NN with_IN the_DT licensed_JJ asset_NN through_IN collaboration_NN or_CC other_JJ arrangement_NN ._.
ii_FW Medeva_FW goodwill_NN adjustments_NNS Under_IN US_NNP GAAP_NNP the_DT time_NN frame_NN allowed_VBN to_TO make_VB adjustments_NNS to_TO goodwill_NN is_VBZ one_CD year_NN from_IN the_DT date_NN of_IN acquisition_NN ,_, except_IN for_IN adjustments_NNS in_IN respect_NN of_IN taxation_NN when_WRB an_DT indefinite_JJ period_NN is_VBZ available_JJ ._.
Under_IN UK_NNP GAAP_NNP the_DT time_NN frame_NN available_JJ extends_VBZ to_TO the_DT first_JJ full_JJ reporting_NN period_NN after_IN the_DT reporting_NN period_NN in_IN which_WDT the_DT acquisition_NN was_VBD made_VBN ._.
Thus_RB a_DT longer_JJR period_NN to_TO make_VB goodwill_NN adjustments_NNS is_VBZ generally_RB available_JJ under_IN UK_NNP GAAP_NNP ._.
Consequently_RB certain_JJ adjustments_NNS were_VBD booked_VBN to_TO goodwill_NN arising_VBG on_IN the_DT Medeva_NNP acquisition_NN during_IN 2001_CD for_IN the_DT purpose_NN of_IN the_DT UK_NNP accounts_NNS ._.
These_DT have_VBP flowed_VBN through_IN the_DT profit_NN and_CC loss_NN account_NN for_IN US_NNP GAAP_NNP purposes_NNS during_IN 2001_CD and_CC 2002_CD ._.
iii_FW Amortisation_NNP of_IN goodwill_NN and_CC other_JJ intangibles_NNS Under_IN US_NNP GAAP_NNP the_DT merger_NN between_IN Celltech_NNP and_CC Chiroscience_NNP failed_VBD to_TO qualify_VB as_IN a_DT pooling_VBG of_IN interest_NN and_CC therefore_RB additional_JJ goodwill_NN and_CC intangible_JJ assets_NNS were_VBD established_VBN on_IN the_DT US_NNP balance_NN sheet_NN ._.
In_IN addition_NN ,_, amortisation_NN is_VBZ no_RB longer_RB automatically_RB charged_VBN under_IN SFAS_NNP 142_CD Goodwill_NNP and_CC other_JJ intangible_JJ assets_NNS on_IN goodwill_NN ._.
Amortisation_NNP continues_VBZ to_TO be_VB applied_VBN in_IN the_DT US_NNP on_IN finite_JJ life_NN intangibles_NNS whilst_VBP goodwill_NN and_CC indefinite_JJ life_NN intangibles_NNS are_VBP tested_VBN for_IN impairment_NN annually_RB ._.
iv_NN Inventory_NN adjustment_NN The_DT 2001_CD adjustment_NN relates_VBZ to_TO the_DT Thiemann_NNP acquisition_NN and_CC the_DT 2000_CD adjustment_NN to_TO the_DT Medeva_NNP acquisition_NN ._.
Under_IN UK_NNP GAAP_NNP ,_, inventory_NN is_VBZ recognized_VBN at_IN replacement_NN cost_NN ._.
Under_IN US_NNP GAAP_NNP ,_, inventory_NN is_VBZ recognized_VBN at_IN selling_VBG price_NN less_RBR an_DT allowance_NN for_IN selling_VBG costs_NNS ._.
v_NNP Stock_NNP based_VBN compensation_NN Under_IN UK_NNP GAAP_NNP ,_, no_DT compensation_NN expense_NN is_VBZ recorded_VBN in_IN connection_NN with_IN the_DT issue_NN of_IN share_NN options_NNS to_TO Group_NNP employees_NNS at_IN market_NN value_NN ._.
Under_IN US_NNP GAAP_NNP ,_, APB_NNP 25_CD ,_, an_DT annual_JJ compensation_NN expense_NN is_VBZ imputed_JJ for_IN variable_JJ stock_NN option_NN plans_VBZ based_VBN on_IN the_DT excess_NN of_IN the_DT then_RB prevailing_VBG market_NN price_NN over_IN grant_NN price_NN ._.
vi_FW Unrealised_JJ gains_NNS on_IN derivative_JJ financial_JJ instruments_NNS As_IN described_VBN in_IN note_NN 1_CD to_TO the_DT accounts_NNS financial_JJ instruments_NNS the_DT Group_NNP uses_VBZ forward_RB exchange_NN contracts_NNS to_TO match_VB against_IN forecast_NN receipts_NNS and_CC payments_NNS in_IN foreign_JJ currency_NN ._.
As_IN the_DT contracts_NNS are_VBP not_RB matched_VBN to_TO specific_JJ receivables_NN or_CC payables_NNS the_DT gains_NNS or_CC losses_NNS arising_VBG on_IN the_DT hedges_NNS are_VBP not_RB recognized_VBN until_IN such_JJ time_NN as_IN they_PRP are_VBP realized_VBN under_IN UK_NNP GAAP_NNP ._.
SFAS_NNP 133_CD determines_VBZ that_IN under_IN such_JJ circumstances_NNS recognition_NN should_MD be_VB made_VBN of_IN the_DT gains_NNS or_CC losses_NNS that_WDT have_VBP arisen_VBN in_IN the_DT profit_NN and_CC loss_NN account_NN ._.
The_DT Group_NNP adopted_VBD SFAS_NNP 133_CD during_IN 2001_CD and_CC accordingly_RB the_DT adjustment_NN recognized_VBN in_IN that_DT year_NN takes_VBZ into_IN account_NN the_DT cumulative_JJ effect_NN of_IN this_DT change_NN in_IN accounting_NN policy_NN ._.
vii_FW Deferred_JJ taxation_NN The_DT Group_NNP adopted_VBD FRS_NNP 19_CD during_IN 2001_CD resulting_VBG in_IN prior_JJ year_NN adjustments_NNS to_TO goodwill_NN and_CC deferred_VBN taxation_NN under_IN UK_NNP GAAP_NNP ._.
Under_IN US_NNP GAAP_NNP no_DT deferred_JJ tax_NN liability_NN is_VBZ recognized_VBN in_IN a_DT purchase_NN business_NN combination_NN for_IN which_WDT amortisation_NN is_VBZ not_RB deductible_JJ for_IN tax_NN purposes_NNS ._.
Consequently_RB the_DT FRS_NNP 19_CD adjustments_NNS have_VBP been_VBN reversed_VBN ._.
viii_FW Employee_NNP Share_NNP Ownership_NNP Plan_NNP ESOP_NNP Under_IN UK_NNP GAAP_NNP the_DT Companys_NNP own_JJ shares_NNS held_VBN by_IN the_DT ESOP_NNP are_VBP recorded_VBN as_IN fixed_JJ asset_NN investments_NNS at_IN cost_NN ._.
Under_IN US_NNP GAAP_NNP those_DT shares_NNS not_RB fully_RB vested_VBN are_VBP regarded_VBN as_IN treasury_NN stock_NN and_CC recorded_VBN at_IN cost_NN as_IN a_DT deduction_NN from_IN shareholders_NNS equity_NN ._.
ix_NN Pensions_NNS other_JJ comprehensive_JJ income_NN Under_IN US_NNP GAAP_NNP ,_, a_DT minimum_JJ pension_NN liability_NN is_VBZ recognized_VBN through_IN other_JJ comprehensive_JJ income_NN in_IN certain_JJ circumstances_NNS when_WRB there_EX is_VBZ a_DT deficit_NN of_IN plan_NN assets_NNS relative_JJ to_TO the_DT projected_VBN benefits_NNS obligation_NN ._.
Under_IN UK_NNP GAAP_NNP ,_, there_EX is_VBZ no_DT such_JJ requirement_NN ._.
